Lv1
22 积分 2025-01-10 加入
THERAPEUTIC OLIGONUCLEOTIDES, IMPURITIES, DEGRADANTS, AND THEIR CHARACTERIZATION BY MASS SPECTROMETRY
7小时前
待确认
SynONIM: A Comprehensive Database of Synthetic Oligonucleotide Modifications and Impurities to Aid in Their Characterization by Mass Spectrometry
7小时前
已完结
Densities and Apparent Molar Volumes of Atmospherically Important Electrolyte Solutions. 1. The Solutes H2SO4, HNO3, HCl, Na2SO4, NaNO3, NaCl, (NH4)2SO4, NH4NO3, and NH4Cl from 0 to 50 °C, Including Extrapolations to Very Low Temperature and to the Pure Liquid State, and NaHSO4, NaOH, and NH3 at 25 °C
7天前
已完结
Strategies for Identity Testing of Therapeutic Oligonucleotide Drug Substances and Drug Products
18天前
已完结
Circular Antisense Oligonucleotides for Specific RNase-H-Mediated microRNA Inhibition with Reduced Off-Target Effects and Nonspecific Immunostimulation
26天前
已完结
Characterizing the Diastereoisomeric Distribution of Phosphorothioate Oligonucleotides by Metal Ion Complexation Chromatography, In-Series Reversed Phase-Strong Anion Exchange Chromatography, and 31P NMR
1个月前
已完结
Assessment of Stereochemical Comparability in Phosphorothioated Oligonucleotides by CD, 31P NMR, and NP1 Digestion Coupled to LC-MS
1个月前
已完结
Real-Time Process Analytical Technology Assurance for Flow Synthesis of Oligonucleotides
3个月前
已完结
Oligonucleotide Purification by Ion Exchange Chromatography: A Step-by-Step Guide to Process Understanding, Modeling, and Simulation
3个月前
已完结
Design of experiments (DoE) in pharmaceutical development
5个月前
已完结
皖公网安备34019202002308
